PATENT CLAIM ANALYSIS

Application Number: 16033464
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["540", "586000"]

Abstract:
There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).

Claim (Index 22):
A compound of formula (X) wherein LG is a leaving group such as a halogen atom, especially chlorine and R a  is lower alkyl such as ethyl; or a salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.35294
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15642637', '15902077', '15305003', '15516809', '15524472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.730656757858755
- 35 USC 102 Novelty (BERT): 0.5158487035142048
- Combined Prediction Score: 0.7091759524242999
- Mean Citation Score: 263.912802
- Max Citation Score: 268.62714
- Similarity Product: 175.997490353415

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test